BRENNEN COMEAUX: Open Payments
NPI 1780248518 · EAST POINT, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,353 in 117 payments from 16 companies in 2025. Trend: 2023 $1,914 · 2024 $1,838 · 2025 $2,353
Food & beverage: $2,353
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 27 | $798 |
| Otsuka America Pharmaceutical, Inc. | 26 | $414 |
| Teva Pharmaceuticals USA, Inc. | 22 | $304 |
| E.R. Squibb & Sons, L.L.C. | 4 | $179 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $168 |
| Axsome Therapeutics, Inc. | 8 | $132 |
| ABBVIE INC. | 3 | $67 |
| Luye Pharma (USA) Ltd. | 2 | $54 |
| Corium, LLC | 4 | $44 |
| Lundbeck LLC | 2 | $40 |
Products named: INGREZZA, REXULTI, COBENFY, CAPLYTA, AUSTEDO XR, UZEDY, Auvelity, ABILIFY MAINTENA.
Industry payments across GA — which companies pay providers there.
